Polymer-Metal Nanoparticle Hybrid Systems for Targeted Breast Cancer Therapy: Advances and Clinical Translation
Overall, polymer-metal hybrid nanoparticles represent a versatile and promising nanomedicine platform for precision breast cancer management, with continued advances in nanoparticle engineering, safety assessment, and clinical validation expected to facilitate their successful translation into personalized oncology.